American Shared Hospital Services to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention

SAN FRANCISCO–(BUSINESS WIRE)– American Shared Hospital Services (NYSE MKT:AMS) announced today that
Ernest A. Bates, M.D. and Craig K. Tagawa will be presenting on
behalf of the company at the Sidoti & Company Fall 2016 Emerging Growth
Convention in New York City.

The company is scheduled to deliver a presentation at 10:25 am EST.
Investors interested in attending and scheduling a one-on-one meeting
with management should click the link here.

About the Sidoti & Company Emerging Growth Convention

The Sidoti & Company Fall 2016 Emerging Growth Convention will focus on
companies with market capitalizations of $600 million and less,
connecting their executive management teams with institutional and
high-net-worth investors while building interest and visibility into the
most overlooked, undervalued segment of the equity market.

About Sidoti & Company, LLC

Sidoti & Company, founded in 1999, is Wall Street’s preeminent provider
of equity research generally focused on companies with market
capitalizations of under $3 billion. Sidoti & Company’s approach affords
institutional investor clients a combination of high-quality research of
over 250 companies, a small- and micro-cap company focused nationwide
sales effort, broad access to corporate management teams, and extensive
trading support. Sidoti & Company serves nearly 500 institutional
clients in the U.S., Canada and the U.K., including many leading
managers of portfolios with $200 million to $2 billion of assets. They
also host a biannual Emerging Growth Convention in New York, and is a
provider of company sponsored research. For more information, please
refer to Sidoti
& Company

About AMS

American Shared Hospital Services provides turnkey technology solutions
for advanced radiosurgical and radiation therapy services. AMS is the
world leader in providing Gamma Knife radiosurgery equipment, a
non-invasive treatment for malignant and benign brain tumors, vascular
malformations and trigeminal neuralgia (facial pain). The Company also
offers proton therapy, the latest IGRT and IMRT systems, as well as its
proprietary Operating Room for the 21st Century^SM concept.
AMS owns a common stock investment in Mevion Medical Systems, Inc.,
developer of the compact MEVION S250 Proton Therapy System.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161026006724/en/